Iain Stuart
CIK 1727756 · CHIEF SCIENTIFIC OFFICER · last filed 2026-04-02
Iain Stuart is a CHIEF SCIENTIFIC OFFICER who has filed 43 SEC Form 4 insider transactions across 3 companies since 2018. The most recent filing shows the insider had shares withheld for taxes covering $1.7K of VYNE on Apr 2, 2026. Across all open-market trades the lifetime net is −$27.1K, making them a net seller over the disclosed history. Current disclosed insider exposure totals $72.9K across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$72.9K
3
43
-$27.1K
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| VYNE | CHIEF SCIENTIFIC OFFICER | 112,363 | $0.65 | $72.9K | $0 | 28 | 2026-04-02 |
| VYNE Therapeutics Inc. (MNLO) Delisted | Chief Scientific Officer | 291,018 | — | — | $0 | 5 | 2020-07-02 |
| Foamix Pharmaceuticals Ltd. (FOMX) Delisted | Chief Scientific Officer | 103,636 | — | — | -$27.1K | 9 | 2020-02-24 |
Recent Filings
43 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-04-02 | VYNE | Tax (F) | −2,876 | -$1.7K | EDGAR |
| 2026-01-05 | VYNE | Tax (F) | −2,448 | -$1.4K | EDGAR |
| 2025-10-02 | VYNE | Tax (F) | −2,453 | -$822 | EDGAR |
| 2025-07-02 | VYNE | Tax (F) | −2,453 | -$4.0K | EDGAR |
| 2025-04-02 | VYNE | Tax (F) | −6,044 | -$9.5K | EDGAR |
| 2025-01-23 | VYNE | Grant (A) | — | $0 | EDGAR |
| 2025-01-02 | VYNE | Tax (F) | −4,857 | -$16.3K | EDGAR |
| 2024-10-02 | VYNE | Tax (F) | −109 | -$205 | EDGAR |
| 2024-07-03 | VYNE | Tax (F) | −138 | -$265 | EDGAR |
| 2024-04-03 | VYNE | Tax (F) | −157 | -$484 | EDGAR |